Patient Experience

Patient Experience

Melmar-T

Melanoma Margins Trial (MelMarT): A Phase III, multi centre, multi national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma
Description: This is a surgical trial comparing 2 different surgeries for patients with primary cutaneous melanoma- a 1cm excision margin v a 2cm wide excision margin
Study Phase: Phase 3
Principal Investigator: Ms Marlese Dempsey
Further information

R3767-ONC-2011

A PHASE 3 TRIAL OF FIANLIMAB (REGN3767, ANTI-LAG-3) +CEMIPLIMAB VERSUS PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
Description: This trial assesses the effectiveness of Fianlimab + Cemiplimab v's Pembrolizumab in patients with untreated locally advanced or metastatic melanoma
Study Phase: Phase 3
Principal Investigator: Dr Fergal Kelleher
Further information

Enquire about a Cancer Clinical Trial

If you would like more information on Cancer Clinical Trials you can contact us.

Make an enquiry